Legal Disclaimer
These products are intended for research and laboratory use only. Not intended for human or veterinary use. Not for diagnostic or therapeutic procedures. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Showing 13–21 of 21 results
-
PT-141
A synthetic melanocortin receptor agonist widely studied for its role in melanocortin signaling pathways involved in neuroendocrine and physiological research.
-
Retatrutide
A next-generation triple receptor agonist that activates GIP, GLP-1, and glucagon receptor for advanced metabolic research and multi-pathway metabolic optimization.
-
Semaglutide
A GLP-1 receptor agonist that mimics naturally occurring incretin hormones, making it a valuable tool for metabolic and endocrine research.
-
Sermorelin
A synthetic peptide similar to naturally occurring GHRH that prompts the pituitary gland to release HGH in a pulse-mimicking nocturnal pattern.
-
TB-500
A synthetic fragment of Thymosin Beta-4 that regulates actin to promote cell migration, angiogenesis, and structural tissue repair.
-
Tesamorelin
A synthetic growth hormone-releasing hormone (GHRH) analog studied for its ability to stimulate endogenous growth hormone secretion and support metabolic research.
-
Thymosin Alpha-1
A thymus-derived peptide that acts as an immune modulator, enhancing the maturation of T-cells for adaptive immunity.
-
Tirzepatide
A dual GIP and GLP-1 receptor agonist designed to support research into metabolic regulation through complementary incretin signaling pathways.
-
Wolverine Stack (BPC-157 / TB-500)
A targeted protocol inspired by rapid healing, focusing on connective tissue integrity, circulation, and muscle recovery.